Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$20,995,778
+$279,823 QoQ
Shares Held
133,970
-1.2% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
4.58%
of 13F equity value
Holder Rank
#117
of 1,603 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Coleford Investment Management Ltd. holds $20,995,778 across 1 Drug Manufacturers - General name. NVS ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
This page
|
133,970 | $20,995,778 |
All Filings in NVS
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $20,995,778 | 133,970 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $20,715,955 | 135,620 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $18,429,772 | 133,675 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $17,447,052 | 136,050 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $16,790,137 | 138,750 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $15,551,460 | 139,500 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $13,824,053 | 142,062 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||